Home LiteratureArticle Details
PMID: 3702918 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Progress against cancer?

The New England journal of medicine ·Vol. 314 ·No. 19 ·1986-05-08 ·Pages 1226-32

Bailar JC, Smith EM

Abstract

We assessed the overall progress against cancer during the years 1950 to 1982. In the United States, these years were associated with increases in the number of deaths from cancer, in the crude cancer-related mortality rate, in the age-adjusted mortality rate, and in both the crude and the age-adjusted incidence rates, whereas reported survival rates (crude and relative) for cancer patients also increased. In our view, the best single measure of progress against cancer is change in the age-adjusted mortality rate associated with all cancers combined in the total population. According to this measure, we are losing the war against cancer, notwithstanding progress against several uncommon forms of the disease, improvements in palliation, and extension of the productive years of life. A shift in research emphasis, from research on treatment to research on prevention, seems necessary if substantial progress against cancer is to be forthcoming.

MeSH Terms
Age Factors Breast Neoplasms/mortality Colonic Neoplasms/mortality Female Humans Lung Neoplasms/mortality Male Neoplasms/epidemiology,mortality Prostatic Neoplasms/mortality Rectal Neoplasms/mortality Stomach Neoplasms/mortality United States
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Bailar J C
Smith E M
Article Info
Journal
The New England journal of medicine
Abbr.
N Engl J Med
ISSN
0028-4793
Published
1986-05-08
Pages
1226-32
Language
English
Region
United States
NLM ID
0255562
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com